期刊文献+

药源性男性乳腺发育症 被引量:7

Drug-induced Male Mammary Development
下载PDF
导出
摘要 药物引起男性乳腺发育症(gynecomastia.GYN)占所有GYN的10%~25%.临床常用药物度他雄胺、非那雄胺、螺内酯、利培酮、西咪替丁等均可诱发男性乳腺发育症。本文通过对诱发男性乳腺发育的药物及其诱发GYN的作用机制进行分析总结,并概括了药源性GYN的诊断和治疗,以期为临床提供参考。 Drug-induced male mammary development (gynecomastia, GYN) accounts for 10% - 25% of all GYN.Clinical commonly used drugs such as finasteride, spironolactone, risperidone, cimetidine, etc all can induce male mammary development. This article tried to understand male breast development mechanism of action of drugs and it induced GYN, and summarized the diagnosis and treatment of drug-induced GYN, expecting to provide reference for clinical.
出处 《药品评价》 CAS 2016年第3期13-18,共6页 Drug Evaluation
关键词 男性乳腺发育症 药物 不良反应 雌激素 雄激素 Male Mammary Development Drugs Adverse Reactions Estrogen Androgen
  • 相关文献

参考文献36

  • 1Bowman JD, Kim H, Bustamante JJ. Drug-induced gynecomastia[J]. Pharmacotherapy, 2012, 32(12): 1123-1140.
  • 2Eckman A, Dobs A. Drug-induced gynecomastia[J]. 2008, 7(6): 691-702.
  • 3Czajka 1, Zgliczynski W. Gynecomastia--pathogenesis, diagnosis and treatment[J]. Endokrynol Pol, 2005, 56(3): 269-277.
  • 4Rose LI, Underwood RH, Newmark SR, eta/. Pathophysiology of spironolactone- induced gynecomastia[J]. Ann Intern Med, 1977, 87(4): 398-403.
  • 5Huffman DH, Kampmann JP, Hignite CE, et al. Gynecomastia induced in normal males by spironolaetone[J]. Clin Pharmacol Yher, 1978, 24(4): 465-473.
  • 6Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure[J]. N Engl J Med, 1999, 341(10): 709-717.
  • 7Autorino R, Perdona S, D'Armiento M, et al. Gynecomastia in patients with prostate cancer: update on treatment options[J]. Prostate Cancer Prostatic Dis, 2006, 9(2): 109-114.
  • 8Flaig TW, Glode LM. Management of the side effects of androgen deprivation therapy in men with prostate cancer[J]. Expert Opin Pharmacother, 2008, 9(16): 2829-2841.
  • 9Kim HS, Freedland SJ. Androgen deprivation therapy in prostate cancer: a*nticipated side-effects and their management[J]. Current opinion in supportive and palliative care, 2010, 4(3): 147-152.
  • 10Thompson CA, Shanafelt TD, Loprinzi CL. Andropause: symptom management for prostate cancer patients treated with hormonal ablation[J]. The oncologist, 2003, 8(5): 474-487.

二级参考文献43

  • 1Ishimi Y,Takano F,Yamauchi J,et al. Study on food labeling and the content of soybean isoflavones in health foods [ J ]. Japanese Journal of Nutrition and Dietetics,2009,67(2) :49-57.
  • 2Peterson C A, Schnell J D, Kubas K L, et al. Effects of soy isoflavone consumption on bone structure and milk mineral concentration in a rat model of lactation-associated bone loss[ J]. European Journal of Nutrition,2009,48(2) :84-91.
  • 3Li S H, Liu X X, Bai Y Y, et al. Effect of oral isoflavone supplementation on vascular endothelial function in postmenopansal women: a meta-analysis of randomized placebo-controlled trials [J]. The American Journal of Clinical Nutrition,2010,91 (2) : 480-486.
  • 4Ward H A, Kuhnle G G, Mulligan A A, et al. Breast, colorectal, and prostate cancer risk in the European Prospective Investigation into cancer and nutrition-norfolk in relation to phytoestregen intake derived from an improved database [ J ]. The American Journal of Clinical Nutrition ,2010,91 (2) :440-448.
  • 5Xu W H,Zhang W,Xiang Y B,et al. Soya food intake and risk of endometfial cancer among Chinese women in Shanghai:population based case-control study [ J ]. British Medical Journal, 2004,328 : 1285-1289.
  • 6Lee S A, Shu X O, Li H L, et al. Adolescent and adult soy food intake and breast cancer risk : results from the Shanghai women' s health study [ J ]. The American Journal of Clinical Nutrition, 2009,89 (6) : 1920-1926.
  • 7Thanos J, Cotterchio M, Boucher B A, et al. Adolescent dietary phytoestrogen intake and breast cancer risk(Canada) [ J]. Cancer Causes and Control ,2009,90(5 ) : 1172-1178.
  • 8Li S H, Liu X X, Bai YY, et al. Effect of oral isoflavone supplementation on vascular endothelial function in postmenopausal women: a meta-analysis of randomized placebo-controlled trials [J]. The American Journal of Clinical Nutrition,2010,91 (2) : 480.486.
  • 9Hooper L, Ryder J J, Kurzer M S, et al. Effects of soy protein and isoflavones on circulating hormone concentrations in pre-and post- menopausal women : a systematic review and meta-analysis [ J ]. Human Reproduction Update,2009,15 (4) :423-40.
  • 10Sakai T, Kogiso M. Soy isoflavones and immunity [ J ]. The Journal of Medical Investigation ,2008,55 : 167-173.

共引文献7

同被引文献34

引证文献7

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部